These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28480270)
21. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy. Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113 [TBL] [Abstract][Full Text] [Related]
22. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy. Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO mBio; 2021 Mar; 12(2):. PubMed ID: 33688002 [TBL] [Abstract][Full Text] [Related]
23. Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy. Hileman C; Longenecker C; Carman T; Milne G; Labbato DE; Storer Nj; White C; McComsey G HIV Med; 2012 Nov; 13(10):609-16. PubMed ID: 22624591 [TBL] [Abstract][Full Text] [Related]
24. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794 [TBL] [Abstract][Full Text] [Related]
25. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection. O'Halloran JA; Dunne E; Gurwith M; Lambert JS; Sheehan GJ; Feeney ER; Pozniak A; Reiss P; Kenny D; Mallon P HIV Med; 2015 Nov; 16(10):608-19. PubMed ID: 26111187 [TBL] [Abstract][Full Text] [Related]
26. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. Torriani FJ; Komarow L; Parker RA; Cotter BR; Currier JS; Dubé MP; Fichtenbaum CJ; Gerschenson M; Mitchell CK; Murphy RL; Squires K; Stein JH; J Am Coll Cardiol; 2008 Aug; 52(7):569-76. PubMed ID: 18687253 [TBL] [Abstract][Full Text] [Related]
27. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Hsue PY; Ribaudo HJ; Deeks SG; Bell T; Ridker PM; Fichtenbaum C; Daar ES; Havlir D; Yeh E; Tawakol A; Lederman M; Currier JS; Stein JH Clin Infect Dis; 2019 May; 68(11):1877-1886. PubMed ID: 30219823 [TBL] [Abstract][Full Text] [Related]
28. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV; J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472 [TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. Hatano H; Scherzer R; Wu Y; Harvill K; Maka K; Hoh R; Sinclair E; Palmer S; Martin JN; Busch MP; Deeks SG; Hsue PY J Acquir Immune Defic Syndr; 2012 Nov; 61(3):317-25. PubMed ID: 22918156 [TBL] [Abstract][Full Text] [Related]
30. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848 [TBL] [Abstract][Full Text] [Related]
31. Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy. Hileman CO; Longenecker CT; Carman TL; Milne GL; Labbato DE; Storer NJ; White CA; McComsey GA Antivir Ther; 2012; 17(7):1345-9. PubMed ID: 22878464 [TBL] [Abstract][Full Text] [Related]
33. Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery. Tenore SB; Avelino-Silva VI; Costa PR; Franco LM; Sabino EC; Kalil J; Cerqueira NB; Nakagawa Z; Kallas EG AIDS; 2020 Mar; 34(3):381-389. PubMed ID: 31714353 [TBL] [Abstract][Full Text] [Related]
34. Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals. Yadav A; Kossenkov AV; Knecht VR; Showe LC; Ratcliffe SJ; Montaner LJ; Tebas P; Collman RG Pathog Immun; 2019; 4(2):324-362. PubMed ID: 31893252 [TBL] [Abstract][Full Text] [Related]
35. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection. Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS; Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952 [TBL] [Abstract][Full Text] [Related]
36. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection. Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T Front Immunol; 2021; 12():738743. PubMed ID: 34630420 [TBL] [Abstract][Full Text] [Related]
37. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children. Ananworanich J; Kerr SJ; Jaimulwong T; Vibol U; Hansudewechakul R; Kosalaraksa P; Ngampiyaskul C; Kanjanavanit S; Wongsawat J; Luesomboon W; Apornpong T; Soulas C; Paul R; Ruxrungtham K; Puthanakit T J Virus Erad; 2015; 1(3):196-202. PubMed ID: 26835517 [TBL] [Abstract][Full Text] [Related]
38. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial. Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153 [TBL] [Abstract][Full Text] [Related]
39. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Kelesidis T; Tran TT; Stein JH; Brown TT; Moser C; Ribaudo HJ; Dube MP; Murphy R; Yang OO; Currier JS; McComsey GA Clin Infect Dis; 2015 Aug; 61(4):651-60. PubMed ID: 25904376 [TBL] [Abstract][Full Text] [Related]
40. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. de Jong W; Aerts J; Allard S; Brander C; Buyze J; Florence E; van Gorp E; Vanham G; Leal L; Mothe B; Thielemans K; Plana M; Garcia F; Gruters R; Trials; 2019 Jun; 20(1):361. PubMed ID: 31208472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]